首页> 外文期刊>Bone marrow transplantation >A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs.
【24h】

A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs.

机译:一种量化健康造血SCT的健康供体和小儿受体中KIR表达的新方法。

获取原文
获取原文并翻译 | 示例
       

摘要

The killer cell Ig-like receptor (KIR) expression repertoire may offer valuable information for hematopoietic SCT (HSCT). We designed a quantitative KIR RNAtype assay and used it to determine KIR gene expression in healthy donors and patients before HSCT. The specificity of the assay was ensured by specific primers and by electrophoretic distinction of PCR products of unique length. In 87 healthy donors, the KIR repertoire was broadly distributed (32 categories of profiles). There was an overall trend toward inverse correlation of KIR expression level and donor age. Age affected mainly the activating KIR families. Leukemia patients showed lower KIR expression before transplantation than healthy donors. Stem cell mobilization caused a transient increase of KIR expression. We conclude that KIR expression differs quantitatively with age and primary disease and is transiently altered by stem cell recruitment and selection.
机译:杀伤细胞Ig样受体(KIR)表达库可能为造血SCT(HSCT)提供有价值的信息。我们设计了一种定量的KIR RNA类型测定法,并用于确定健康供体和HSCT之前患者中的KIR基因表达。通过特异性引物和独特长度的PCR产物的电泳区分,确保了测定的特异性。在87个健康的捐献者中,KIR资料库分布广泛(32种概况)。 KIR表达水平与供体年龄呈负相关的总体趋势。年龄主要影响活跃的KIR家庭。白血病患者移植前的KIR表达低于健康供体。干细胞动员引起KIR表达的瞬时增加。我们得出的结论是,KIR表达在数量上随年龄和原发疾病而不同,并且会因干细胞募集和选择而暂时改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号